Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis

Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis

(2012) Zhu Xiangyang et al.   CYTOKINE

TheFCGR2Brs10917661 polymorphism may confer susceptibility to ankylosing spondylitis in Han Chinese: a case–control study

(2012) Z-H Duan et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

(2011) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Serum levels of IL-33 is increased in patients with ankylosing spondylitis

(2011) Guo-Wei Han et al.   CLINICAL RHEUMATOLOGY

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

(2011) Koichi Yanaba et al.   CLINICAL RHEUMATOLOGY

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis

(2011) Yeon-Sik Hong et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population

(2010) Zaixing Yang et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis

(2010) Minoru Hasegawa et al.   CLINICAL RHEUMATOLOGY

Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis

(2010) R. MU et al.   JOURNAL OF RHEUMATOLOGY

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

(2009) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production

(2009) Elvire Bourgeois et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-33–activated dendritic cells induce an atypical TH2-type response

(2009) Matthew A. Rank et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

(2009) M. Y. Mok et al.   RHEUMATOLOGY

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33

(2008) T. Pecaric-Petkovic et al.   BLOOD

IL-33 reduces the development of atherosclerosis

(2008) Ashley M. Miller et al.   JOURNAL OF EXPERIMENTAL MEDICINE